Answers are grounded in this paper and cite their sources.
To assess the 1) Acceptability and feasibility of online and paper versions of the MEPA III screener in patients with Parkinson's disease (PD), and 2) Test retest reliability of the screener. For the first objective, participants with PD completed the online and paper screeners five to seven days apart followed by an exit questionnaire. The latter included a 65-point system usability scoring (SUS) method.
No takes yet. Share an insight, caveat, or question.
Ribbens et al. (2020) studied this question.
Synapse has enriched 9 related papers. Consider them for comparative context: